This webinar will explore how the GI360™ provides a comprehensive view of the microbiome and dysbiosis, with insights into GLP-1 signaling pathways. Learn practical applications for patients with GI, autoimmune, cardiovascular, neurological, or skin conditions, and discover how stool insights can guide better clinical outcomes.
Learning Objectives:
1. Describe the GI360™ complimentary methodologies and applications
2. Identify patients who benefit from stool testing
3. Interpret markers of dysbiosis and GLP-1–modulating bacteria
4. Apply targeted probiotics, soluble fiber, diet, and dysbiosis therapies to support microbiome health and GLP-1 signal pathways
5. Explain the role of retesting for optimizing microbiome and GLP-1–related outcomes
References to webinars are from our accredited laboratory network. Health care providers are encouraged to explore the original source material and apply their clinical expertise when interpreting this information.